Article Sidebar
Keywords:
snake bite rural South Africa
Article Details
Issue
Section
Articles
By submitting manuscripts to SAFP, authors of original articles are assigning copyright to the SA Academy of Family Practice/Primary Care. Copyright of review articles are assigned to the Publisher, Medpharm Publications (Pty) Ltd, unless otherwise specified. Authors may use their own work after publication without written permission, provided they acknowledge the original source. Individuals and academic institutions may freely copy and distribute articles published in SAFP for educational and research purposes without obtaining permission.
Main Article Content
Management of snakebites at a rural South African hospital
Abstract
Background: Snakebites remain a source of considerable morbidity and mortality in many countries, with an estimated global true incidence of
envenomation exceeding five million a year, with about 100 000 of these cases developing severe sequelae. Despite the availability of polyvalent
snake antivenom, inappropriate first aid, regional effects of envenomation and inappropriate use of antivenom result in significant and at times
potentially avoidable morbidity and mortality, particularly in children. The study was undertaken in Lephalale (previously Ellisras) Hospital, Limpopo
Province, due to the frequency of snakebites managed at the hospital.
Methods: This was a record-based retrospective study in which patient files with the diagnosis of snakebite were reviewed. The objective of this
study was to document the management of snakebites at Lephalale Hospital, a rural hospital in South Africa. The hospital files of all patients managed at the hospital for snakebites from 1 January 1998 to 31 December 2001 were reviewed.
Results: Seventy patients were treated for snakebites during the study period. The results showed a male preponderance (60%) and a mean age
of 27.3 years among the reported cases. Twenty-nine patients (41.1%) were bitten between dusk and dawn (18:00 and 06:00), 43 (61.4%) were
bitten on the lower limb and the mean duration of admission in the wards was 4.2 days. Twenty-one bites (30%) were attributed to known poisonous
snakes, 22 (31.4%) patients received polyvalent antivenom, 42 (60%) received promethazine, which has not been shown to prevent anaphylactic
reactions, 12 (17.1%) developed complications and two died (a case fatality rate of 2.9%). None of the patients was given tetanus toxoid as
prophylaxis, as no previous tetanus immunisation was documented.
Conclusions: The findings of this study highlight gaps in the management of snakebites at this rural hospital where they were treated frequently. It
is crucial for primary care physicians to be familiar with the most common venomous snakes in South Africa and the management of their bites in
humans. Elevation of the affected limb, administration of intravenous fluids and administration of analgesia, with close monitoring of patients during and after antivenom administration, form the basis of most clinical protocols on the management of snakebites.
envenomation exceeding five million a year, with about 100 000 of these cases developing severe sequelae. Despite the availability of polyvalent
snake antivenom, inappropriate first aid, regional effects of envenomation and inappropriate use of antivenom result in significant and at times
potentially avoidable morbidity and mortality, particularly in children. The study was undertaken in Lephalale (previously Ellisras) Hospital, Limpopo
Province, due to the frequency of snakebites managed at the hospital.
Methods: This was a record-based retrospective study in which patient files with the diagnosis of snakebite were reviewed. The objective of this
study was to document the management of snakebites at Lephalale Hospital, a rural hospital in South Africa. The hospital files of all patients managed at the hospital for snakebites from 1 January 1998 to 31 December 2001 were reviewed.
Results: Seventy patients were treated for snakebites during the study period. The results showed a male preponderance (60%) and a mean age
of 27.3 years among the reported cases. Twenty-nine patients (41.1%) were bitten between dusk and dawn (18:00 and 06:00), 43 (61.4%) were
bitten on the lower limb and the mean duration of admission in the wards was 4.2 days. Twenty-one bites (30%) were attributed to known poisonous
snakes, 22 (31.4%) patients received polyvalent antivenom, 42 (60%) received promethazine, which has not been shown to prevent anaphylactic
reactions, 12 (17.1%) developed complications and two died (a case fatality rate of 2.9%). None of the patients was given tetanus toxoid as
prophylaxis, as no previous tetanus immunisation was documented.
Conclusions: The findings of this study highlight gaps in the management of snakebites at this rural hospital where they were treated frequently. It
is crucial for primary care physicians to be familiar with the most common venomous snakes in South Africa and the management of their bites in
humans. Elevation of the affected limb, administration of intravenous fluids and administration of analgesia, with close monitoring of patients during and after antivenom administration, form the basis of most clinical protocols on the management of snakebites.
